1. Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring during the coronavirus disease 2019 (COVID-19) public health emergency (revised): guidance for industry and Food and Drug Administration staff Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, October 2020 Subject(s): COVID-19Monitoring, PhysiologicRemote Sensing TechnologyUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
